Tumor growth rate and lenvatinib efficacy in radioiodine-refractory differentiated thyroid cancer Meeting Abstract


Authors: Leboulleux, S.; Lee, E. K.; Bastholt, L.; Tahara, M.; Wirth, L. J.; Sherman, S. I.; Robinson, B. G.; Teng, A.; Joshi, P.; Misir, S.; Dutcus, C. E.; Tuttle, R. M.; Schlumberger, M. J.
Abstract Title: Tumor growth rate and lenvatinib efficacy in radioiodine-refractory differentiated thyroid cancer
Meeting Title: 43rd ESMO Congress (ESMO 2018)
Journal Title: Annals of Oncology
Volume: 29
Issue: Suppl. 8
Meeting Dates: 2018 Oct 19-23
Meeting Location: Munich, Germany
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2018-10-01
Start Page: mdy302
Language: English
ACCESSION: WOS:000459277304184
PROVIDER: wos
DOI: 10.1093/annonc/mdy302
Notes: Meeting Abstract: 1819O -- Appears on page viii645 of the abstract book -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Robert M Tuttle
    481 Tuttle